Mankind Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Profit before tax

2,390.36

2,259.57

1,562.84

1,797.54

1,440.21

Net cashflow-operating activity

2,322.16

1,982.97

1,798.99

812.29

1,022.33

Net cash used in investing activity

-12,114.68

-1,919.12

-1,040.61

-1,369.34

-1,127.16

Netcash used in fin. activity

9,845.34

-8.68

-710.41

578.92

88.87

Net inc/dec in cash and equivlnt

50.54

55.07

47.96

21.87

-15.96

Cash and equivalnt begin of year

149.75

134.13

86.17

22.58

77.50

Cash and equivalnt end of year

200.29

189.20

134.13

44.45

61.53